Thorlef Spickschen
Chairman en German Kidney Foundation .
Perfil
Thorlef Spickschen is a businessperson who has been at the head of 6 different companies.
He is on the board of Ruprecht-Karls-Universität Heidelberg, Biovision AG and Innovation GmbH and Chairman for German Kidney Foundation.
In the past he was Managing Director-Germany & Central Europe at Eli Lilly & Co., Chairman-Supervisory Board of Biotest AG, Chairman & Chief Executive Officer of Knoll AG, Chairman & Chief Executive Officer at BASF Pharma Ltd., Chairman-Executive Board at Roche Diagnostics GmbH and Chairman-Executive Board at Boehringer Mannheim GmbH.
Dr. Spickschen received a doctorate from Universität zu Köln.
Cargos activos de Thorlef Spickschen
Empresas | Cargo | Inicio |
---|---|---|
Biovision AG | Director/Board Member | 18/05/2010 |
Innovation GmbH | Director/Board Member | 18/05/2010 |
Ruprecht-Karls-Universität Heidelberg | Director/Board Member | 13/01/2011 |
German Kidney Foundation | Chairman | - |
Antiguos cargos conocidos de Thorlef Spickschen.
Empresas | Cargo | Fin |
---|---|---|
CLOVIS ONCOLOGY, INC. | Director/Board Member | 10/07/2023 |
BIOTEST AG | Chairman | 10/05/2012 |
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO. | Director/Board Member | 07/03/2008 |
BASF Pharma Ltd.
BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The private company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Chief Executive Officer | 01/01/2001 |
Knoll AG
Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The private company is based in Haren, Germany. | Chief Executive Officer | 01/01/2001 |
Formación de Thorlef Spickschen.
Universität zu Köln | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
BIOTEST AG | Health Technology |
Empresas privadas | 10 |
---|---|
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO. | Health Technology |
Knoll AG
Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The private company is based in Haren, Germany. | Health Technology |
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland. | Commercial Services |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the private company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
BASF Pharma Ltd.
BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The private company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Health Technology |
Biovision AG | |
Clovis Oncology, Inc.
Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of innovative anti-cancer agents in the United States, Europe, and additional international markets. Its U.S. marketed product, Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is approved for use in the maintenance treatment and treatment of eligible adult patients with recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer, and also for the treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC), which have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy. In Europe, Rubraca is approved for use in recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. The company was founded by Andrew R. Allen, Gillian C. Ivers-Read, Patrick J. Mahaffy, and Erle T. Mast on April 20, 2009 and is headquartered in Boulder, CO. | Health Technology |
Innovation GmbH | |
German Kidney Foundation | |
Boehringer Mannheim GmbH |